Brief reportHippocampal atrophy in first episode depression: A meta-analysis of magnetic resonance imaging studies
Introduction
Initial reports of hippocampal volume in depression suffered from limited resolution of early neuroimaging methods leading to poor separation of the hippocampus and adjacent structures (reviewed in: Fu et al., 2003). More recent meta-analyses have convincingly established that reduced hippocampal volume is a neurobiological feature of major depressive disorder, particularly in illnesses characterised by recurrent episodes and in chronic depression (Campbell and MacQueen, 2004, McKinnon et al., 2009, Videbech and Ravnkilde, 2004). However, the stage at which hippocampal atrophy begins in depression is unclear. In first episode depression, the evidence has been equivocal, with some studies observing decreased hippocampal volume (Cole et al., 2010, Frodl et al., 2002), while others have reported no significant difference (Eker et al., 2010, Kronmüller et al., 2009).
The presence of hippocampal atrophy from disease onset would have significant etiological and clinical implications as it would support a model of depression in which structural abnormalities appear earlier than previously believed with potentially deleterious effects on clinical outcome and response to antidepressant therapy (MacQueen and Frodl, 2010). In the present study, we sought to establish whether hippocampal atrophy exists from disease onset. We performed a random effects meta-analysis of magnetic resonance imaging studies of hippocampal volume in first episode depression.
Section snippets
Literature search
MEDLINE, EMBASE, Scopus and PsychINFO electronic databases were queried with the following search terms: “depression”, “major depressive disorder”, “magnetic resonance imaging”, “hippocampus”, and abbreviations “MDD”, “MRI”, “unipolar” for papers published between January 1990 and February 2011. References from the retrieved papers and reviews of hippocampal and regional brain volumes in major depressive disorder (MDD) were also inspected for relevant articles.
Inclusion criteria were: 1)
Results
A total of 7 independent studies (Cole et al., 2010, Eker et al., 2010, Kaymak et al., 2010, Kronmüller et al., 2009, MacQueen et al., 2003, Meisenzahl et al., 2010, van Eijndhoven et al., 2009) met our inclusion and exclusion criteria, reporting measurements of 191 patients with a first episode of depression (Table 1, additional methodological study characteristics in Supplementary Table A, Supplementary Table B). Briefly, all studies had recruited adult patients (mean age: 37.6 years, weighted
Discussion
The present meta-analysis establishes that hippocampal volume loss is not only a feature of recurrent and chronic depression but is also evident in adult patients with a first episode of the illness. Hippocampal volume reduction in first episode patients has also been recently demonstrated using whole-brain voxel-based morphometry (Zou et al., 2010). These findings can be linked with recent studies reporting smaller hippocampal volume in subjects at high risk for depression due to a family
Role of funding source
Funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.
Conflict of interest
All authors declare that they have no conflicts of interests.
Acknowledgements
JC was supported by a Medical Research Council PhD studentship. SGC was supported by the National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health award to the South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, King's College London.
References (33)
- et al.
Subregional hippocampal deformations in major depressive disorder
J. Affect. Disord.
(2010) - et al.
Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment
Neuroimage
(2011) - et al.
Meta-analysis in clinical trials
Control. Clin. Trials
(1986) - et al.
Regulation of adult neurogenesis by antidepressant treatment
Neuropsychopharmacology
(2001) - et al.
An analysis of memory dysfunction in major depression
J. Affect. Disord.
(1995) - et al.
Defining the human hippocampus in cerebral magnetic resonance images–an overview of current segmentation protocols
Neuroimage
(2009) - et al.
Hippocampal volume in first episode and recurrent depression
Psychiatry Res.
(2009) - et al.
Regional specificity of hippocampal volume reductions in first-episode schizophrenia
Neuroimage
(2004) - et al.
Hippocampal changes associated with early-life adversity and vulnerability to depression
Biol. Psychiatry
(2010) - et al.
Amygdala volume marks the acute state in the early course of depression
Biol. Psychiatry
(2009)
Changes of brain morphometry in first-episode, drug-naive, non-late-life adult patients with major depression: an optimized voxel-based morphometry study
Biol. Psychiatry
Antidepressants increase neural progenitor cells in the human hippocampus
Neuropsychopharmacology
The role of the hippocampus in the pathophysiology of major depression
J. Psychiatry Neurosci.
Decreased hippocampal volume in healthy girls at risk of depression
Arch. Gen. Psychiatry
Correlation of serum BDNF levels with hippocampal volumes in first episode, medication-free depressed patients
Eur. Arch. Psychiatry Clin. Neurosci.
Hippocampal changes in patients with a first episode of major depression
Am. J. Psychiatry
Cited by (256)
Saikosaponin a activates tet1/dll3/notch1 signalling and promotes hippocampal neurogenesis to improve depression-like behavior in mice
2024, Journal of EthnopharmacologyHippocampal subfield volumes predict treatment response to oral ketamine in people with suicidality
2024, Journal of Psychiatric ResearchDifferences in gray matter volumes of subcortical nuclei between major depressive disorder with and without persistent depressive disorder
2023, Journal of Affective DisordersApigenin attenuates depressive-like behavior via modulating monoamine oxidase A enzyme activity in chronically stressed mice
2023, Current Research in Pharmacology and Drug Discovery